Inaktiver Wert

Andere Sprachen Arena Pharmaceuticals, Inc. Nasdaq

Aktien

US0400471027

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

Longboard Pharmaceuticals, Inc. and Arena Pharmaceuticals, Inc. Executes into Second Amendment to That Certain License Agreement	19.09.22
Biopharma Stocks Targeting Crohn's Disease In $13.7 Billion Market (STAB, ARNA, GILD and RDHL)	16.03.22
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P Biotechnology Select Industry Index	15.03.22
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P TMI Index	15.03.22
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P Global BMI Index	15.03.22
Pfizer Completes Acquisition of Arena Pharmaceuticals	14.03.22
Pfizer Completes $6.7 Billion Acquisition of Arena Pharmaceuticals	11.03.22
Arena Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K	11.03.22
ARENA PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	11.03.22
Arena Pharmaceuticals, Inc. Announces Board Changes	11.03.22
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from NASDAQ Biotechnology Index	11.03.22
Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from NASDAQ Composite Index	11.03.22
Pfizer Inc. completed the acquisition of Arena Pharmaceuticals, Inc..	11.03.22
ARENA PHARMACEUTICALS INC : Other Events (form 8-K)	10.03.22
ARENA PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23.02.22
Arena Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	23.02.22
Arena Pharmaceuticals Extends Q4 Loss, Reports Higher Revenue	23.02.22
Arena Pharmaceuticals : Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates - Form 8-K	23.02.22
Earnings Flash (ARNA) ARENA PHARMACEUTICALS Reports Q4 Revenue $54,000, vs. Street Est of $0.732M	23.02.22
Earnings Flash (ARNA) ARENA PHARMACEUTICALS Reports Q4 Loss $-2.54, vs. Street Est of $-2.23	23.02.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Arena Pharmaceuticals, Inc. Nasdaq

Aktien

US0400471027

Andere Sprachen

Filter